Syndax Pharmaceuticals, Inc. (SNDX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr),…
Source: Yahoo Finance
Sector & Industry
Syndax Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Syndax Pharmaceuticals, Inc. at a Glance
| Company | Syndax Pharmaceuticals, Inc. |
| Ticker | SNDX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $20.56 |
| Market cap | $1.84B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$2.51 |
| 52-week high | $25.59 |
| 52-week low | $12.99 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.37 |
| Return on equity (ROE) | -255.93% |
| Debt-to-equity | 3903.45% |
| Average volume | 1.69M |
| Shares outstanding | 89.30M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 298 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Syndax Pharmaceuticals, Inc.'s current P/E ratio?
- Syndax Pharmaceuticals, Inc. (SNDX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Syndax Pharmaceuticals, Inc.'s market capitalisation?
- Syndax Pharmaceuticals, Inc.'s market cap is $1.84B based on our latest snapshot. See how it ranks by market cap →
- What is SNDX's 52-week range?
- Over the past 52 weeks, SNDX has traded between $12.99 and $25.59. What does the 52-week range mean? →
- How volatile is Syndax Pharmaceuticals, Inc. compared to the market?
- Syndax Pharmaceuticals, Inc. has a beta of 0.37, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Syndax Pharmaceuticals, Inc. pay a dividend?
- Syndax Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is SNDX listed on?
- SNDX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Syndax Pharmaceuticals, Inc. in?
- Syndax Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →